19Indexed trials
mesh condition
Impulsive Behavior
Intelligence
Impulsive Behavior intelligence: 19 indexed trials, 2 recruiting studies, 18 sponsors across 10 countries.
2Recruiting
18Sponsors
10Countries
Leading sponsors
Rhodes Pharmaceuticals, L.P.20 recruiting
Children's Hospital of Philadelphia10 recruiting
Erasmus Medical Center10 recruiting
Hospices Civils de Lyon11 recruiting
Hospital Vall d'Hebron10 recruiting
King's College London10 recruiting
Lauren Kenworthy10 recruiting
National Institute of Mental Health (NIMH)10 recruiting
Oregon Health and Science University10 recruiting
Pharmasoft10 recruiting
Poitiers University Hospital10 recruiting
Shalvata Mental Health Center10 recruiting
Geographic activity
United States7trials
France3trials
Israel2trials
Canada2trials
Hungary1trials
Germany1trials
Netherlands1trials
Russia1trials
Spain1trials
Hong Kong1trials
Leading interventions
Atomoxetine1trials
Broad Spectrum Micronutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants1trials
Compound Natural Health Product1trials
DNA extraction and genotyping of candidate genetic polymorphisms1trials
Methylphenidate Hydrochloride Extended Release Capsule1trials
Methylphenidate Hydrochloride Extended Release Capsules1trials
Mexidol1trials
Mexidol + Placebo1trials
Nicotine Patch, 7 Mg/24 Hr1trials
Parents and Teachers Supporting Students (PATSS)1trials
Phosphatidylserine-Omega31trials
Administration of a PET radiotracer1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.